Abridge was not founded as a “GPT wrapper.” It was established in 2018, well before the explosion of AI application-layer companies. OpenAI publicly released ChatGPT on November 30, 2022, and by then, Abridge had already spent years doing the unglamorous but essential foundational work required for one of the richest and most important workflows in healthcare: the conversation between patients and clinicians.
Abridge initially entered through clinical documentation. It listened to patient visits, generated medical notes, reduced administrative burden, and helped clinicians spend more time with patients instead of the electronic health record (EHR). By focusing on how doctors actually document, how health systems actually buy, how EHR integrations actually work, how clinicians validate outputs, and how missing visit context turns into downstream friction in billing, prior authorization, quality management, and follow-up, LLM adoption became a multiplier that further amplified a workflow already optimized around capturing sensitive context.
The company has scaled quickly: Abridge says it is on track this year to support 80M+ patient-clinician conversations across 250 large, complex health systems in the U.S., with support for 28+ languages and 50+ specialties. It raised $300 million in June 2025 at a $5.3 billion valuation, following a $250 million round earlier that year.